Detalhe da pesquisa
1.
Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen.
PLoS Pathog
; 18(8): e1010764, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969621
2.
Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant.
Infect Immun
; 87(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31308083
3.
Whoop! There it is: The surprising resurgence of pertussis.
PLoS Pathog
; 16(7): e1008625, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702023
4.
Unique T cell signatures are associated with reduced Chlamydia trachomatis reinfection in a highly exposed cohort.
bioRxiv
; 2023 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577476
5.
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization.
Front Immunol
; 14: 1181876, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275891